Ragaglitazar: a novel PPARα & PPARγ agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal modelsCHAKRABARTI, Ranjan; VIKRAMADITHYAN, Reeba K; MISRA, Parimal et al.British journal of pharmacology. 2003, Vol 140, Num 3, pp 527-537, issn 0007-1188, 11 p.Article

Antidiabetic and hypolipidemic activity of Helicteres isora in animal modelsCHAKRABARTI, Ranjan; VIKRAMADITHYAN, Reeba K; MULLANGI, Ramesh et al.Journal of ethnopharmacology. 2002, Vol 81, Num 3, pp 343-349, issn 0378-8741Article

(-)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: A dual PPAR agonist with potent antihyperglycemic and lipid modulating activityLOHRAY, Braj B; LOHRAY, Vidya B; MAMIDI, N. V. S. Rao et al.Journal of medicinal chemistry (Print). 2001, Vol 44, Num 16, pp 2675-2678, issn 0022-2623Article

Antidiabetic and hypolipidemic potential of DRF 2519: a dual activator of PPAR-α and PPAR-γCHAKRABARTI, Ranjan; MISRA, Parimal; VIKRAMADITHYAN, Reeba K et al.European journal of pharmacology. 2004, Vol 491, Num 2-3, pp 195-206, issn 0014-2999, 12 p.Article